Optimal prostate-specific antigen cutoff linked to improved prostate cancer survival
After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an…
Rising metastatic prostate cancer rates but narrowing racial gap | BMC Medicine
In this study, we investigated race-based trends in the incidence of metastatic PCa from 2005 to 2021 as…
Study confirms PSA screening improves survival and safety
The 23-year ERSPC trial reveals that sustained, protocolized PSA testing lowers prostate cancer deaths and improves the benefit-to-harm…